Press-release for stocks for AXSM

Prices are updated after-hours

symbols : AXSM

save search

Axsome Therapeutics and the Global Alzheimer’s Disease Community Come Together in Raising Support for the Millions Affected by This Illness During Alzheimer’s Disease Awareness Month 2023
Published: 2023-11-02 (Crawled : 11:00) - globenewswire.com
FNCTF | News | $11.0354 320

Communications

| -6.08% | O: 4.34% H: 0.0% C: 0.0%
AXSM | $67.19 2.24% 200K

Health Technology

| 1.7% | O: 1.13% H: 1.36% C: -1.45%
disease alzheimer’s global therapeutics

Cybin Announces Unprecedented Positive Phase 2 Interim Data for CYB003 in Major Depressive Disorder Meeting Primary Efficacy Endpoint with Rapid and Significant Improvements in Depression Symptoms After Single Dose
Published: 2023-10-31 (Crawled : 23:00) - biospace.com/
CYBN | News | $0.367 -0.78% 560K

n/a

| -38.64% | O: 11.35% H: 9.32% C: -4.16%
JNJ | News | $146.39 0.45% 1.8M

Health Technology

| -1.41% | O: 0.33% H: 0.0% C: 0.0%
AXSM | $67.19 2.24% 200K

Health Technology

| 9.48% | O: 0.0% H: 3.76% C: 3.75%
cyb003 rapid positive depression meeting

Axsome Therapeutics to Present at Upcoming Investor Conferences
Published: 2023-10-31 (Crawled : 11:00) - globenewswire.com
AXSM | $67.19 2.24% 200K

Health Technology

| 9.48% | O: 0.0% H: 3.76% C: 3.75%
therapeutics

Axsome Therapeutics Presents Results of the ACCORD trial of AXS-05 in Alzheimer’s Disease Agitation at the Clinical Trials on Alzheimer’s Disease (CTAD) 2023 Conference
Published: 2023-10-24 (Crawled : 11:00) - globenewswire.com
AXSM | $67.19 2.24% 200K

Health Technology

| 5.98% | O: 1.98% H: 2.15% C: 0.76%
axs-05 conference disease alzheimer’s trials trial therapeutics results

Axsome Therapeutics Appoints Dr. Sue Mahony to its Board of Directors
Published: 2023-10-11 (Crawled : 11:00) - globenewswire.com
ZYME | $8.89 2.54% 110K

Health Technology

| 37.21% | O: -0.16% H: 0.93% C: 0.85%
LLY | $731.1 -1.99% 1M

Health Technology

| 31.55% | O: 4.47% H: 2.11% C: 1.52%
AXSM | $67.19 2.24% 200K

Health Technology

| -6.86% | O: -0.11% H: 1.04% C: -0.41%
therapeutics

Axsome Therapeutics to Report Third Quarter 2023 Financial Results on November 6
Published: 2023-10-10 (Crawled : 11:00) - globenewswire.com
AXSM | $67.19 2.24% 200K

Health Technology

| -6.62% | O: 0.01% H: 1.19% C: 0.24%
report therapeutics financial results

Diffuse Cutaneous Systemic Sclerosis Market to Proliferate at a Considerable Growth Rate by 2032, Estimates DelveInsight | Leading Companies in the Market - Kyowa Kirin Acceleron, Cumberland, Horizon, CSL Behring, Seagen, Janssen
Published: 2023-10-05 (Crawled : 21:00) - prnewswire.com
SNY | News | $46.34 2.09% 620K

Health Technology

| -15.68% | O: -0.19% H: 0.0% C: 0.0%
AXSM | $67.19 2.24% 200K

Health Technology

| -2.43% | O: -1.5% H: 5.49% C: 3.39%
companies sclerosis growth market

Small-Cell Lung Cancer Market to Accelerate Substantially During the Study Period (2019-2032), Assesses DelveInsight | Leading Companies - Amgen, Novartis, AbbVie, BMS, Clovis Oncology, Cardiff Oncology, Roche, Daiichi Sankyo
Published: 2023-10-04 (Crawled : 21:00) - prnewswire.com
LLY | $731.1 -1.99% 1M

Health Technology

| 43.21% | O: 1.72% H: 0.0% C: 0.0%
RVMD S | $35.0 -2.32% 190K

Health Technology

| 51.27% | O: -0.58% H: 4.83% C: 4.38%
IOVA M | $11.33 -3.33% 1.4M

Health Technology

| 188.51% | O: 0.24% H: 3.66% C: 1.95%
BNTX | $87.02 0.99% 140K

Health Technology

| -21.83% | O: -0.44% H: 1.52% C: 0.08%
AXSM | $67.19 2.24% 200K

Health Technology

| 1.72% | O: -0.43% H: 4.97% C: 4.71%
lung companies cancer study market

Narcolepsy Market Analysis, Market Size, Epidemiology, and Competitive Analysis of Leading Companies Including Takeda, Suven Life Sciences Limited, Axsome Therapeutics, Inc., Avadel, and Others by DelveInsight
Published: 2023-10-03 (Crawled : 21:00) - prnewswire.com
LLY | $731.1 -1.99% 1M

Health Technology

| 39.79% | O: -2.39% H: 0.0% C: 0.0%
AXSM | $67.19 2.24% 200K

Health Technology

| 2.96% | O: -0.66% H: 2.5% C: 1.89%
ACAD | $16.97 -0.59% 200K

Health Technology

| -17.18% | O: -0.82% H: 5.05% C: 4.42%
companies life narcolepsy sciences market

Axsome Therapeutics Joins the National Alliance on Mental Illness and Others Advocating for the Importance of Mental Health on Mental Illness Awareness Week
Published: 2023-10-02 (Crawled : 11:00) - globenewswire.com
AXSM | $67.19 2.24% 200K

Health Technology

| -5.97% | O: 0.16% H: 0.0% C: -4.5%
health week therapeutics

Axsome Therapeutics Joins the Global Narcolepsy Community in Raising Awareness on World Narcolepsy Day
Published: 2023-09-21 (Crawled : 11:00) - globenewswire.com
AXSM | $67.19 2.24% 200K

Health Technology

| -10.83% | O: -1.42% H: 3.9% C: 2.86%
day narcolepsy world global therapeutics

Attention-Deficit/Hyperactivity Disorder Market to Grow Rapidly by 2032, Predicts DelveInsight | Key Companies in the Market - Cingulate, Otsuka, Supernus, Neurocentria, ABVC BioPharma, Axsome, BioLite, Mind Medicine
Published: 2023-09-11 (Crawled : 16:00) - prnewswire.com
SUPN | $29.32 1.56% 45K

Health Technology

| -5.62% | O: 0.88% H: 0.0% C: -3.5%
AXSM | $67.19 2.24% 200K

Health Technology

| -18.51% | O: 0.4% H: 0.26% C: -0.46%
companies market

Axsome Therapeutics Highlights Commitment to Innovating Treatments for Mental Health Conditions with Presentations at Psych Congress 2023
Published: 2023-09-07 (Crawled : 11:00) - globenewswire.com
AXSM | $67.19 2.24% 200K

Health Technology

| -16.62% | O: 3.77% H: 0.55% C: -0.45%
health congress therapeutics

Axsome Therapeutics to Present at Three Upcoming Investor Conferences
Published: 2023-09-05 (Crawled : 11:00) - globenewswire.com
MS | News | $91.305 1.16% 1.7M

Finance